Three Reasons I’d Sell British American Tobacco plc Today

British American Tobacco plc (LON:BATS) is a cash cow that’s on life support, says Roland Head.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

At the risk of alienating readers who remain fans of income favourite British American Tobacco (LSE: BATS) (NYSE: BTI.US), I would like to issue a warning today, explaining why I think that, like many of its customers, British American Tobacco is not as healthy as it appears to be, and deserves a sell rating.

Falling volumes

The first thing to understand about the tobacco industry is that it is in decline. Despite strong growth powered by the insertion of western premium tobacco brands into emerging markets, BAT’s ‘stick volumes’ have fallen by 12% over the last 10 years, from 792bn in 2003 to just 694bn in 2012.

Admittedly, that’s still a lot of cigarettes — but how many other companies manage to convince shareholders that a 12% reduction in sales over 10 years is good news?

Life support machine

BAT has kept shareholders happy with a trio of rising metrics — earnings per share, operating margin and dividend per share — which form a life support machine for the firm’s share price.

BAT’s ample free cash flow is used for two main purposes, share buybacks (2012: £1.3bn) and dividends (2012: £2.5bn). A decreasing number of shares mean that it’s easier to generate increased earnings per share, even on lower sales, and also helps keep the dividend bill under control.

Dividends and buybacks totalled £3.8bn last year, but BAT’s post-tax profits were only £4.1bn. Eventually, I expect these two numbers to meet, after which the firm’s dividends and buyback programmes will come under pressure.

Analysts’ forecasts for the firm suggest that City insiders may agree with my view. After years of double-digit earnings per share growth, consensus forecasts suggest an increase in EPS of 8.7% in 2013 and just 7.5% in 2014.

Too much debt?

My final concern about BAT — ignoring legislative risks — relates to its net gearing of 153%. BAT’s net finance costs totalled £241m during the first half of this year, accounting for 8.6% of its operating profits, and equating to a net interest rate of around 4.5%, which is almost identical to BAT’s prospective dividend yield.

In my view, the firm should be concentrating on reducing its £10.7bn net debt, while borrowing costs remain low. The firm’s board will be reluctant to do this until it’s forced to — but in my view now is a much better time to sell BAT shares than to buy them.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Roland does not own shares in British American Tobacco.

More on Investing Articles

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »